Anti-obesity medication (naltrexone/bupropion) in obesity management: single-centre early experience
Background: Naltrexone/bupropion is a recently approved antiobesity medication in Malaysia. We aimed to determine the 12-week outcomes of naltrexone/bupropion as an antiobesity medication at our centre. Methods: This was a single-centre, prospective, pilot, observational study. All patients prescrib...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | en |
| Published: |
Penerbit Universiti Sains Malaysia
2025
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/121029/1/121029.pdf http://psasir.upm.edu.my/id/eprint/121029/ http://www.mjms.usm.my/MJMS32022025/05-mjms-11-2024-879.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|